
Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Fierce editors discuss the future of Gilead Sciences, biotech's continued slump on Wall Street, and the latest move in Sanofi's efforts to right the ship.
Gilead's wide-open future, biotech's long winter, and Sanofi's ongoing makeover is an episode from FierceBiotech Radio. Fierce editors discuss the future of Gilead Sciences, biotech's continued slump on Wall Street, and the latest move in S...
This episode belongs to FierceBiotech Radio.
Use the player on this page to stream the episode online.
Published Feb 4, 2016, 36:41 long, audio available.